首页|基于中医传承辅助平台挖掘中药治疗小儿霰粒肿的用药规律

基于中医传承辅助平台挖掘中药治疗小儿霰粒肿的用药规律

扫码查看
目的 基于中医传承数据平台挖掘探索中药治疗小儿霰粒肿的组方规律.方法 选取建库至2022年11月中国知网、万方和维普数据库中关于中药治疗小儿霰粒肿的文献.将收集到处方录入中医传承计算平台(V3.0)软件中,统一中药名称后,对药物的属性、用药频次和功效等进行分析.结果 (1)一般情况:共纳入符合标准的处方共57个,涉及中药151味,累计使用频次位582次.中药四气以寒性最多(69味,45.92%),五味以苦味药最多(54味,35.92%),归经以肺经最多(41味,27.27%).(2)高频中药使用频次:使用频次≥12次的中药(高频中药)共12味.排在前5位的依次是陈皮(29次,4.98%)、半夏(26次,4.47%)、茯苓(26次,4.47%)、甘草(24次,4.12%)、连翘(17次,2.92%).(3)高频中药功效分类:以清热药最多,138次(23.71%),其次为化痰止咳药(60次,10.30%)、解表药(54次,9.27%)、补虚药(44次,7.56%)、理气药(40次,6.87%).(4)高频中药聚类分析:共得到6类组方,功效依次为益气健脾,燥湿化痰;消食导滞,益气和胃;化痰散结,健脾化湿;清热解毒,消散疔疮;明目退翳,化痰散结;降逆蠲饮,宁心定悸.(5)高频中药关联规则分析:关联性较强的5对为陈皮-茯苓,陈皮-半夏,半夏-甘草,陈皮-僵蚕,陈皮-连翘.结论 小儿霰粒肿的中医药用药以清热解毒、化痰散结为主,配以益气健脾、清肝疏风类,为临床医生提供药物参考及治疗思路.
Excavating the Medication Rule of Traditional Chinese Medicine in Treating Chil-dren with Chalazion based on Support Platform of TCM Inheritance
OBJECTIVE To explore the prescription patterns of Traditional Chinese Medicine(TCM)in the treatment of chalazion in children based on the TCM Inheritance Assisting Platform.METHODS Relevant literature on TCM treatment of chalazion in children was collected from the China National Knowledge Infrastructure(CNKI),Wanfang Data,and VIP databases from the establishment of the databases to November 2022.The collected prescriptions were input into the TCM Inheritance Assisting Platform(V3.0),and after standardizing the names of Chinese medicines,the properties,frequency of use,and therapeutic effects of Chinese medicines were analyzed.RESULTS(1)General Information:A total of 57 prescriptions met the criteria,involving 151 different Chinese medicines with a cumulative frequency of use of 582 times.Among these Chinese medicines,cold-natured Chinese medicines were the most commonly used(69 medicines,45.92%),bitter-taste Chinese medicines were the most prevalent among the five tastes(54 medicines,35.92%),and the lung meridian was the most commonly associated meridian(41 medicines,27.27%).(2)High-frequency Chinese medicines usage:There were 12 high-frequency Chinese medicines with usage frequencies≥12 times.The top five are Pericarpium Citri Reticulatae(29 times,4.98%),Pinellia ternata(26 times,4.47%),Poria cocos(26 times,4.47%),Glycyrrhiza uralensis Fisch(24 times,4.12%)and Forsythia suspensa(17 times,2.92%).(3)Classification of high-frequency Chinese medicines therapeutic effects:The most common therapeutic effect was heat-clearing Chinese medicines(138 times,23.71%),followed by phlegm-resolving and cough-suppressing Chinese medicines(60 times,10.30%),exterior-releasing Chinese medicines(54 times,9.27%),tonifying Chinese medicines(44 times,7.56%),and Qi-regulating Chinese medicines(40 times,6.87%).(4)Cluster analysis of high-frequency herb effects:A total of six categories of prescription effects were identified,including tonifying Qi and strengthening spleen,drying dampness and resolving phlegm,promoting digestion and resolving stagnation,heat-clearing and detoxifying,improving vision and dispersing phlegm,and calming liver and quelling wind.(5)Association rule analysis of high-frequency Chinese medicines:The five strongest associations were found between Pericarpium Citri Reticulatae-Poria cocos,Pericarpium Citri Reticulatae-Pinellia ternata,Pinellia ternata-Glycyrrhiza uralensis Fisch,Pericarpium Citri Reticulatae-Bombyx Batryticatus,Pericarpium Citri Reticulatae-Forsythia suspensa.CONCLUSIONS TCM treatment for chalazion in children primarily involves heat-clearing and detoxification,resolving phlegm and dispersing masses,and is supplemented with Qi-tonifying and liver-calming herbs.This study provides a reference for clinicians in terms of medication and treatment strategies.

chalazionmeibomian gland cystchalazion granulomaTraditional Chinese Medicine treatmentdata miningTraditional Chinese Medicine inheritance assisting platformcompatibility patterns

包银兰、周尚昆、李成武、王立军

展开 >

中国中医科学院望京医院,北京 100102

中国中医科学院广安门医院,北京 100053

霰粒肿 睑板腺囊肿 胞生痰核 中医药治疗 数据挖掘 中医传承计算平台 配伍规律

北京市中医药"薪火传承3+3工程"项目中国中医科学院科技创新工程重大公关课题

C2019CI2021A03609

2024

中国中医眼科杂志
中国中医科学院

中国中医眼科杂志

CSTPCD
影响因子:0.476
ISSN:1002-4379
年,卷(期):2024.34(1)
  • 8